Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
18.58
-0.11 (-0.59%)
At close: Oct 5, 2026, 4:00 PM EDT
19.00
+0.42 (2.26%)
After-hours: Oct 5, 2026, 4:43 PM EDT
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $1.1 billion as of October 5, 2026. Its market cap has increased by 328.14% in one year.
Market Cap
1.10B
Enterprise Value
635.98M
1-Year Change
328.14%
Ranking
Category
Stock Price
$18.58
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $1.10B, a decrease of -15.38%. That is a compound annual growth rate of -2.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 1.10B | 117.04% |
| Dec 31, 2025 | 506.46M | 266.35% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Savara | 1.22B |
| MannKind | 1.22B |
| LB Pharmaceuticals | 1.19B |
| First Tracks Biotherapeutics | 1.19B |
| Bicara Therapeutics | 1.17B |
| Latigo Biotherapeutics | 1.05B |
| Immatics | 1.04B |
| MeiraGTx Holdings | 1.04B |